Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
59
LAB Quote, Financials, Valuation and Earnings
Last price:
$1.25
Seasonality move
:
1.41%
Day range:
$1.21 - $1.26
52-week range:
$0.92 - $2.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.73x
P/B ratio:
0.99x
Volume:
2M
Avg. volume:
2.3M
1-year change:
-45.85%
Market cap:
$447.9M
Revenue:
$174.4M
EPS (TTM):
-$0.35
Earnings Data
Next earnings date for LAB
Jul 31
2025
Most recent earnings per share
-$0.07
Missed by $0.03
(May 6/2025)
Consensus Estimate
-$0.04
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LAB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $40.9M | -- | -- | -$0.04 | -- |
| 07/31/2025 | Q2 | $38.8M | -- | -- | -$0.04 | -- |
| 05/06/2025 | Q1 | $40.1M | $40.8M | -$0.07 | -$0.04 | -$0.03 |
| 02/26/2025 | Q4 | $43M | $46.7M | -$0.09 | -$0.03 | -$0.06 |
| 10/30/2024 | Q3 | $41M | $45M | -$0.07 | -$0.08 | $0.00 |
| 07/31/2024 | Q2 | $48.2M | $37.2M | -$0.12 | -$0.07 | -$0.05 |
| 05/08/2024 | Q1 | $46M | $45.5M | -$0.27 | -$0.10 | -$0.17 |
| 02/28/2024 | Q4 | $24.9M | $28.2M | -$0.25 | -$0.13 | -$0.12 |
| 11/07/2023 | Q3 | $23.6M | $25.4M | -$0.27 | -$0.12 | -$0.15 |
| 08/08/2023 | Q2 | $24.2M | $27.7M | -$0.22 | -$0.10 | -$0.12 |
| 05/09/2023 | Q1 | -- | $25.1M | -$0.21 | -- | -- |
| 02/14/2023 | Q4 | -- | $27M | -$0.26 | -- | -- |
| 11/08/2022 | Q3 | -- | $25.6M | -$0.37 | -- | -- |
| 08/08/2022 | Q2 | -- | $18.8M | -$0.82 | -- | -- |
| 05/05/2022 | Q1 | -- | $26.5M | -$0.99 | -- | -- |
| 02/17/2022 | Q4 | -- | $38.3M | -$0.12 | -- | -- |
| 09/30/2021 | Q3 | -- | $28.5M | -$0.18 | -- | -- |
| 06/30/2021 | Q2 | -- | $31M | -$0.23 | -- | -- |
| 03/31/2021 | Q1 | -- | $32.8M | -$0.25 | -- | -- |
| 12/31/2020 | Q4 | -- | $44.6M | -$0.24 | -- | -- |
| 09/30/2020 | Q3 | -- | $39.9M | -$0.08 | -- | -- |
| 06/30/2020 | Q2 | -- | $26.1M | -$0.18 | -- | -- |
| 03/31/2020 | Q1 | -- | $27.6M | -$0.23 | -- | -- |
| 12/31/2019 | Q4 | -- | $32.4M | -$0.18 | -- | -- |
| 09/30/2019 | Q3 | -- | $26.5M | -$0.19 | -- | -- |
| 06/30/2019 | Q2 | -- | $28.2M | -$0.20 | -- | -- |
| 03/31/2019 | Q1 | -- | $30.1M | -$0.44 | -- | -- |
| 12/31/2018 | Q4 | -- | $32.3M | -$0.36 | -- | -- |
| 09/30/2018 | Q3 | -- | $29M | -$0.38 | -- | -- |
| 06/30/2018 | Q2 | -- | $26.4M | -$0.42 | -- | -- |
| 03/31/2018 | Q1 | -- | $25.2M | -$0.34 | -- | -- |
| 12/31/2017 | Q4 | -- | $27.7M | -$0.27 | -- | -- |
| 09/30/2017 | Q3 | -- | $24.7M | -$0.46 | -- | -- |
| 06/30/2017 | Q2 | -- | $23.9M | -$0.58 | -- | -- |
| 03/31/2017 | Q1 | -- | $25.5M | -$0.59 | -- | -- |
| 12/31/2016 | Q4 | -- | $25.1M | -$0.61 | -- | -- |
| 09/30/2016 | Q3 | -- | $22.2M | -$0.68 | -- | -- |
| 06/30/2016 | Q2 | -- | $28.2M | -$0.64 | -- | -- |
| 03/31/2016 | Q1 | -- | $29M | -$0.69 | -- | -- |
| 12/31/2015 | Q4 | -- | $30.7M | -$0.45 | -- | -- |
| 09/30/2015 | Q3 | -- | $28.6M | -$0.32 | -- | -- |
Standard BioTools Earnings Questions
-
How Much did Standard BioTools Generate in Revenue Last Quarter?
Standard BioTools reported $40.8M worth of top line sales in its most recent quarter.
-
Did Standard BioTools Beat Earnings Last Quarter?
Standard BioTools announced earnings per share of -$0.07 which represents a miss of analyst forecast a -$0.04 per share.
-
Is Standard BioTools Profitable?
Standard BioTools reported $19.7M that represents $0.05 per share over the last quarter.
-
What is the Analyst Consensus for Standard BioTools EPS Next Year?
Standard BioTools's earnings are forecast to decrease from -$0.52 per share to -$0.22 per share next year representing a decrease of -73.08%.
-
When is Standard BioTools's Earnings Date?
Standard BioTools's next earnings date is July 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
